FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/09/094766 [Registered on: 15/09/2025] Trial Registered Prospectively
Last Modified On: 15/09/2025
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Follow Up Study 
Study Design  Non-randomized, Active Controlled Trial 
Public Title of Study   A prospective observational study to assess the role of 18F-FDG PET-CT in evaluating myocardial inflammation immediately after Percutaneous Angioplasty with Myocardial Intervention (PAMi) in patients with coronary artery disease. 
Scientific Title of Study   A Study to assess role of 18F-FDG PET-CT immediately after PAMI in a case of coronary artery disease 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Vigneshwaran M 
Designation  Assistant Professor Nuclear Medicine 
Affiliation  INHS Asvini 
Address  Dept Of Nuclear Medicine INHS Asvini, Near RC Church Colaba
INHS Asvini, Near RC Church
Mumbai
MAHARASHTRA
400005
India 
Phone  8698751411  
Fax    
Email  waranthedon@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Vigneshwaran M 
Designation  Assistant Professor Nuclear Medicine 
Affiliation  INHS Asvini 
Address  Dept Of Nuclear Medicine INHS Asvini, Near RC Church Colaba
INHS Asvini, Near RC Church
Mumbai
MAHARASHTRA
400005
India 
Phone  8698751411  
Fax    
Email  waranthedon@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Bharat S Sambyal 
Designation  Associate Professor, Cardiology 
Affiliation  INHS Asvini 
Address  Department of Cardiology, INHS Asvini, near RC Church, Colaba

Mumbai
MAHARASHTRA
400005
India 
Phone  8384031327  
Fax    
Email  drbharatsambyal@gmail.com  
 
Source of Monetary or Material Support  
INHS Asvini, Governmetn hospital (no external funding) 
 
Primary Sponsor  
Name  Dr Vigneshwaran M 
Address  Dept of Nuclear Medicine, INHS Asvini, Colaba, Mumba-400005 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
Dr Bharat S Sambyal  Depat of Cardiology, INHS Asvini, Mumbai -400005 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Vigneshwaran M  INHS Asvini  Dept Of Nuclear Medicine INHS Asvini, Near RC Church Colaba
Mumbai
MAHARASHTRA 
8698751411

waranthedon@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INHS Asvini Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: I20-I25||Ischemic heart diseases,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Primary angioplasty in myocardial infarction  primary angioplasty done in case of acute ST elevation myocardial infarction as for routine treatment protocol 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  90.00 Year(s)
Gender  Both 
Details  Adult patients who qualify for a need of diagnostic angiography followed by angioplasty
1. Acute ST-elevation myocardial infarction
2. Non ST-elevation myocardial infarction
3. Unstable angina
4. Stable angina
5. Anginal equivalent
6. High risk stress test findings
 
 
ExclusionCriteria 
Details  un willing for 18F-FDG PET-CT
Pregnant women
Psychiatry patients
claustrophobic 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Improvement of Ejection fraction and reperfusion  Improvement of Ejection fraction and reperfusion 
 
Secondary Outcome  
Outcome  TimePoints 
To check for improvement in ejection fraction and reperfusion.
To correlate FDG uptake with procedural details (number of vessels involved, stent placement, and duration).


To assess association between post-PAMi inflammation and serum cardiac biomarkers (e.g., Troponin I, CK-MB, hs-CRP).


To explore predictive value of early PET-CT findings in short-term outcomes (e.g., recurrent angina, re-hospitalization within 30 days).
 
3-6 months 
 
Target Sample Size   Total Sample Size="25"
Sample Size from India="25" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   30/09/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Open to Recruitment 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

This prospective observational study will evaluate the role

of 18F-FDG PET-CT in detecting myocardial inflammation

immediately after Percutaneous Angioplasty with

Myocardial Intervention (PAMi) in patients with coronary

artery disease. PET-CT will be performed within 24–72

hours post-procedure and repeated at 3–6 months to assess

changes in myocardial metabolic activity.

The study aims to correlate early FDG uptake with ejection

fraction, serum biomarkers, procedural details, and short-

term outcomes such as recurrent angina or

rehospitalization. It is hypothesized that early PET-CT can

identify inflammation reflecting procedural impact and

predict recovery, with follow-up scans showing reperfusion

and improvement in cardiac function.


 
Close